Nephros (NEPH) Current Leases (2019 - 2020)
Nephros' quarterly Current Leases came in at $332000.0 in Q4 2020, up 26.72% year-on-year from $262000.0 in Q1 2020, and up 1.84% quarter-over-quarter from $326000.0 in Q3 2020.
Nephros has reported Current Leases for 2 years, with the latest figure at $332000.0 in Q4 2020.
- For the quarter ending Q4 2020, Current Leases rose 26.72% year-over-year to $332000.0; the trailing twelve-month figure through Dec 2020 stood at $332000.0 (up 26.72% YoY), and the FY2020 full-year result was $332000.0, up 26.72% from the prior year.
- Current Leases for Q4 2020 stood at $332000.0, up from $326000.0 in the prior quarter.
- The five-year high for Current Leases was $332000.0 in Q4 2020, with the low at $191000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 29.23 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 21.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 326,000.00 |
| Jun 30, 2020 | 315,000.00 |
| Mar 31, 2020 | 312,000.00 |
| Dec 31, 2019 | 262,000.00 |
| Sep 30, 2019 | 251,000.00 |
| Jun 30, 2019 | 223,000.00 |
| Mar 31, 2019 | 191,000.00 |